Showing results (11-20 of 212) with videos related to
Sort By:
Pageof 22
Cancer Research|October 5, 2006
Identification of an agent selectively targeting DPC4 (deleted in pancreatic cancer locus 4)-deficient pancreatic cancer cellsHong Wang, Haiyong Han, Daniel D Von HoffCancer Treatment Reviews|March 31, 2009
DNA minor groove binders: back in the grooveXuemei Cai, Phillip J Gray, Daniel D Von HoffCancer Journal (Sudbury, Mass.)|July 30, 2015
Orchestrating the Tumor Microenvironment to Improve Survival for Patients With Pancreatic Cancer: Normalization, Not DestructionClifford J Whatcott, Haiyong Han, Daniel D Von HoffCurrent Drug Targets|July 23, 2011
The hedgehog knows many tricksGlen J Weiss, Alain C Mita, Daniel D Von HoffPacific Symposium on Biocomputing. Pacific Symposium on Biocomputing|November 13, 2009
Clustering context-specific gene regulatory networksArchana Ramesh, Robert Trevino, Daniel D VON Hoff, et al.Pancreas|March 12, 2009
Identification and characterization of a novel anticancer agent with selectivity against deleted in pancreatic cancer locus 4 (DPC4)-deficient pancreatic and colon cancer cellsHong Wang, Bret Stephens, Daniel D Von Hoff, et al.Seminars in Oncology|August 8, 2006
Targeting loss-of-function mutations in tumor-suppressor genes as a strategy for development of cancer therapeutic agentsHong Wang, Haiyong Han, Spyro Mousses, et al.Heart Failure Clinics|July 14, 2011
A historical perspective of anthracycline cardiotoxicityMichael S Ewer, Daniel D Von Hoff, Robert S BenjaminCurrent Oncology Reports|April 2, 2008
Tubulin-associated proteins: Aurora and Polo-like kinases as therapeutic targets in cancerSteven L Warner, Bret J Stephens, Daniel D Von HoffSeminars in Oncology|August 8, 2006
Tubulin-associated drug targets: Aurora kinases, Polo-like kinases, and othersSteven L Warner, Phillip J Gray, Daniel D Von HoffPageof 22